metaPreg - Diltiazem (versus unexposed) during pregnancy

Diltiazem (versus unexposed)

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
3 non statistically significant endpoints reported in only one study
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Preterm (< 37 weeks)	3.75 [1.45, 9.65]	-	1 study	53	29	not evaluable	ROB	6.95 [2.27; .]
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Elective/induced termination of pregnancy	4.43 [1.73, 11.35]	-	1 study	36	41	not evaluable	ROB	8.34 [2.86; .]
2 non statistically significant endpoints reported in only one study